Despite a clear association between the occurrence of inactivating MEN1 mutations and tumor onset in cases of sporadic and hereditary MEN1 syndrome, knowledge of how these mutations manifest during pathogenesis remains limited. This evidence concerns the gene MEN1 and neoplasm.